ARTELO BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expenses, Other
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Prepaid Expenses, Other of -$5.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2024-05-13
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2024-03-31 was -$5.00K, a 107.35% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-09-30 was -$256.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-06-30 was -$169.00K, a 118.29% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2023-03-31 was $68.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was $195.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expenses, other for fiscal 2021 was $239.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 3 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 4 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | -$5.00K 10-Q · filed 2024-05-13 | |||||
| 2023-09-30 | -$256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$425.00K derived: sum of 2 quarters · filed 2023-11-13 | -$357.00K 10-Q · filed 2023-11-13 | -$353.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2023-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$101.00K 10-Q · filed 2023-08-10 | -$97.00K derived: sum of 3 quarters · filed 2024-05-13 | -$236.00K derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2023-03-31 | $68.00K 10-Q · filed 2024-05-13 | -$68.00K 10-Q · filed 2023-05-11 | $72.00K derived: sum of 2 quarters · filed 2024-05-13 | -$67.00K derived: sum of 3 quarters · filed 2024-05-13 | $857.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$135.00K derived: sum of 2 quarters · filed 2023-11-13 | $789.00K derived: sum of 3 quarters · filed 2023-11-13 | $195.00K 10-K · filed 2023-03-31 | ||
| 2022-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $785.00K derived: sum of 2 quarters · filed 2023-11-13 | $191.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $924.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $330.00K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$594.00K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | $63.00K 10-K · filed 2023-03-31 | |||||
| 2021-08-31 | $239.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |